Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3774
This examiner grants 73% of resolved cases
Dinah N. Baria, working in Art Unit 3774 of Tech Center 3700, has an allowance rate of 72.9 percent across 649 resolved cases. The median days to allowance is 1006, providing a benchmark for the duration of the prosecution cycle. This 1006-day period allows for a standard prosecution rhythm. Practitioners can use these figures to set expectations for applications entering Art Unit 3774.
The data shows an interview lift of 28.5 percent. While the 72.9 percent allowance rate is already established, the additional lift suggests that interviews remain a productive use of resources to resolve outstanding issues. With 649 resolved cases, these statistics offer a basis for strategic planning. Practitioners can leverage the 28.5 percent lift to further improve the probability of a positive outcome. The combination of the grant rate and the lift makes this examiner approachable for technical dialogue.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18193431 | IMPLANTABLE MEDICAL DEVICE WITH VISUAL INDICATORS | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18267810 | STENTS FOR USE IN THE INTERVENTIONAL TREATMENT OF VASCULAR DISORDERS AND VASCULAR SURGERY | Final Rejection | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
| 18776659 | TISSUE INGROWTH COMPOSITE MATERIAL FOR IMPLANTABLE HEART VALVES | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18737756 | PROSTHETIC VALVE WITH DUAL FRAMES RETAINED BY FABRIC | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18731039 | MULTI-PORTION REPLACEMENT HEART VALVE PROSTHESIS | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18596062 | MULTI-PORTION REPLACEMENT HEART VALVE PROSTHESIS | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18220730 | DILATORS AND SHEATHS WITH EXPANSION FEATURES | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 19320925 | SYSTEMS, DEVICES, AND METHODS RELATING TO THE MANUFACTURE OF INTRAVASCULARLY IMPLANTABLE PROSTHETIC VALVES | Final Rejection | California Institute of Technology |
| 18195535 | DISTAL LIMB PERFUSION CANNULA STENT & STENT CANNULA COVER | Final Rejection | ABIOMED, Inc. |
| 18656886 | HEART VALVE PROSTHESIS | Non-Final OA | Medtronic, Inc. |
| 17684747 | ENDOVASCULAR APPARATUS WITH ENHANCED RETRIEVABILITY AND RELATED METHODS | Non-Final OA | C.R. BARD, INC. |
| 18421615 | BIOABSORBABLE MEDICAL DEVICES | Non-Final OA | W. L. Gore & Associates, Inc. |
| 17203982 | DEVICES AND METHODS FOR APPROXIMATING THE CROSS-SECTIONAL PROFILE OF VASCULATURE HAVING BRANCHES | Final Rejection | W. L. Gore & Associates, Inc. |
| 18458120 | MULTILAYERED VASCULARIZED CONSTRUCT | Non-Final OA | University of Washington |
| 18508539 | BALLOON EXPANDABLE STENT PROSTHESES AND BALLOON EXPANDABLE BRANCHING STENT PROSTHESES | Final Rejection | Merit Medical Systems, Inc. |
| 18456515 | PROSTHETIC HEART VALVE TISSUE DURABILITY STRUCTURE AND METHOD | Final Rejection | MEDTRONIC VASCULAR, INC. |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | Non-Final OA | LifeCell Corporation |
| 18641818 | PERFORATED TISSUE MATRIX | Non-Final OA | LifeCell Corporation |
| 18779403 | TENDON REPAIR IMPLANT AND METHOD OF IMPLANTATION | Non-Final OA | ROTATION MEDICAL, INC. |
| 18683271 | DISK-SHAPED AUGMENTATION FOR A BONE, PARTICULARLY A LONG BONE | Final Rejection | Waldemar Link GmbH & Co. KG |
| 18360284 | A Drug-Eluting Stent Comprising a Biocompatible Thermoplastic Polymer Lining and a Drug- Containing Coating | Final Rejection | SCITECH MEDICAL Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy